Evotec SE and Janssen Biotech Inc have agreed to co-develop targeted immuno-oncological therapies.
Tag Archive for: immunoncology
Atara Biotherapeutics Inc. and Pierre Fabre SA announced the approval of Tabelecleucel, a therapy for a rare and potentially fatal malignancy.